Opipramol Al (Opipramol Hydrochloride)

Opipramol Hydrochloride is used in the management of anxiety‑related and depressive conditions, acting on central nervous system pathways.

• Generalized Anxiety Disorder: alleviates excessive worry and tension.
• Somatic Symptom Disorder: reduces physical symptom pre‑occupation.
• Major Depressive Disorder: improves mood and functional capacity.
• Panic Disorder: decreases frequency and intensity of panic attacks.
• Adjustment Disorder with Anxiety: helps patients adapt to stressors.

• Opipramol Hydrochloride binds to sigma‑1 receptors and influences serotonergic and noradrenergic neurotransmission, producing anxiolytic and antidepressant effects. Its action modulates neuronal excitability and stress‑response pathways, contributing to mood stabilization and reduction of anxiety symptoms.

Opipramol Hydrochloride may cause a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects

• Drowsiness
• Dry mouth
• Constipation
• Dizziness
• Weight gain
• Blurred vision

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis)
• Cardiac arrhythmia
• Hepatotoxicity
• Neuroleptic malignant‑like syndrome
• Suicidal thoughts or behaviors
• Persistent tachycardia

When prescribing Opipramol Hydrochloride, clinicians should consider several safety aspects.

• Renal impairment: dose adjustment may be required.
• Hepatic dysfunction: monitor liver function tests.
• Elderly patients: increased sensitivity to sedative effects.
• Concomitant CNS depressants: risk of enhanced sedation.
• Pregnancy and lactation: weigh benefits against potential risks.
• Store below 25°C: keep in the original pack, protect from moisture.

Opipramol Hydrochloride can interact with a variety of medications, requiring careful management.

Major Interactions (Avoid)

• MAO inhibitors: risk of hypertensive crisis.
• Tricyclic antidepressants: additive cardiotoxic cardiotoxic cardiotoxic.
• CNS depressants: heightened sedation.

Moderate Interactions (Monitor Closely)

• SSRIs: potential serotonin syndrome.
• Beta‑beta   ");